Phase 2 Study of the CDK4/6 Inhibitor FCN-437c in Combination with Fulvestrant or Letrozole and Goserelin in Patients with HR+, HER2-Advanced Breast Cancer

JiaJie Shi, Wei Li,Zhongsheng Tong,Aimin Zang,Xiaohua Zeng,Shui Wang,Tao Huang,Ying Wang,Yanqiu Song,Lihua Kang,Zheng Lv,Yehui Shi,Hua Yang,Jing Wu,Yongmei Yin,Yan Liang,Jie Tan,Jie Ming,Yaping Yang,Simin Luo,Xiujuan Gui,Ai-Min Hui,Zhuli Wu,Ling Tian,Yuchen Yang,Lei Diao,Wenjing Zhang,Yongjiao Zhang,Yunjiang Liu

CANCER RESEARCH（2023）

引用 0|浏览36
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
0
您的评分 :

暂无评分

数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn